Aims. Sleep duration (SD) has been associated with metabolic outcomes. Is there an
independent association between short/long SD and glycemic control (GC) in type 2 …

We appreciate the commentary by Sen et al. 1 As stated, 2 consistent with the design of the
Hygia Chronotherapy Trial (HCT), there were no statistically significant differences at …

Methods: We synthesized randomized controlled studies (RCTs) from the Web of Science,
SCOPUS, EMBASE, PubMed, and CENTRAL until 13 October 2022. The risk ratio (RR) for …

Background Studies have suggested that evening dosing with antihypertensive therapy
might have better outcomes than morning dosing. The Treatment in Morning versus Evening …

Because they were intrigued by the results, many colleagues and journalists have made us
aware of the paper “Bedtime hypertension treatment improves cardiovascular risk reduction …

Objectives Cardiovascular autonomic neuropathy (CAN) and abnormal circadian blood
pressure (BP) rhythm are independent cardiovascular risk factors in patients with diabetes …

Study Objectives: The aim of this study was to investigate the association of bedtime with the
prevalence of diabetes mellitus (DM) based on a large community-based population …

Correlation between blood pressure (BP) and target organ damage, vascular risk and long-
term patient prognosis is greater for measurements derived from around-the-clock …

Introduction To examine the association of sleep duration, insomnia, and obstructive sleep
apnea (OSA) with hemoglobin A1c (HbA1c) in a cohort of patients with type 2 diabetes (T2D) …

There is a strong association between metabolic syndrome (MS) and increased
cardiovascular risk. Moreover, elevated nighttime blood pressure (BP) and non-dipping …